Brief: Cannara Biotech Inc Reports Fourth Quarter And Fiscal Year 2021 Results
Dec 8 (Reuters) - Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC. REPORTS FOURTH QUARTER AND FISCAL
YEAR 2021
RESULTS
* CANNARA BIOTECH INC - QTRLY EPS $0.01
* CANNARA BIOTECH INC - QTRLY TOTAL REVENUE OF $6.5 MILLION
VERSUS
$0.6 MILLION
* CANNARA - ANTICIPATES EXISTING CASH RESOURCES OF $8.2
MILLION,
AS AT AUG 31, TO ENABLE IT TO FUND PLANNED OPERATING EXPENSES
FOR AT LEAST NEXT 12 MONTHS
Source text for Eikon: ID:nPnk9Y4Xa
Further company coverage: LOVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsBrief: Cannara Biotech - Enters Amended Syndicated Credit Agreement With BMO And Td
Cannara Biotech Q3 revenue tops estimates on expanded distribution
Canada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4